Emily Rollins - 10 Aug 2022 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez, as Attorney-in-Fact for Emily Rollins
Issuer symbol
DLB
Transactions as of
10 Aug 2022
Net transactions value
-$80,000
Form type
4
Filing time
12 Aug 2022, 16:53:58 UTC
Previous filing
24 May 2022
Next filing
30 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale $80,000 -1,000 -19% $80.00 4,245 10 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 2,783 restricted stock units, which are subject to forfeiture until they vest.

Remarks:

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.